A new study finds that an experimental Alzheimer’s drug may slow the progression of the disease in its early stages, but it comes with significant side effects. CBS News chief medical correspondent Dr. Jon LaPook joins John Dickerson on “Prime Time” to discuss.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
